Seasonal Allergic Rhinitis In Pediatric Subjects

• Status: Completed
• Trial end date: 2005-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine if the investigational drug is effective and safe in children with seasonal allergic rhinitis.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline

Criteria

Inclusion criteria:

• Diagnosis of seasonal allergic rhinitis.

• Adequate exposure to seasonal (Spring/Summer) allergen prevalent to the geographic area.

Exclusion criteria:

• Have significant concomitant medical conditions.

• Use of corticosteroids, other allergy meds during the study.

• Have abnormal ECG or laboratory abnormality.